Shaking and stirring: Comparison of controlled laboratory stress conditions applied to the human growth hormone

Process Biochemistry

Volumn 48, Issue 1, 2013, Pages 33-40

  Wiesbauer, Johanna ^a,b   Cardinale, Massimiliano ^b   Nidetzky, Bernd ^a,b  

^a RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH   (Austria)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Air liquid interface; Laboratory stress test; Mechanical stress; Protein aggregation; Shaking; Stability; Stirring

Indexed keywords

AIR LIQUID INTERFACES; MECHANICAL STRESS; PROTEIN AGGREGATION; SHAKING; STIRRING; STRESS TEST;

AGGLOMERATION; CHEMICAL MODIFICATION; CONVERGENCE OF NUMERICAL METHODS; DRUG PRODUCTS; OLIGOMERS; PHASE INTERFACES; STABILIZATION; STRESSES; SURFACE CHEMISTRY;

PROTEINS;

EID: 84874106169     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2012.11.007     Document Type: Article

References (72)

1. M.C. Manning, D.K. Chou, B.M. Murphy, R.W. Payne, and D.S. Katayama Stability of protein pharmaceuticals: an update Pharm Res 27 2010 544 575
2. M.C. Manning, K. Patel, and R.T. Borchardt Stability of protein pharmaceuticals Pharm Res 6 1989 903 918
3. W. Wang Instability, stabilization, and formulation of liquid protein pharmaceuticals Int J Pharm 185 1999 129 188
4. E.Y. Chi, S. Krishnan, T.W. Randolph, and J.F. Carpenter Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation Pharm Res 20 2003 1325 1336
5. W. Wang, S. Nema, and D. Teagarden Protein aggregation-pathways and influencing factors Int J Pharm 390 2010 89 99
6. H.-C. Mahler, W. Friess, U. Grauschopf, and S. Kiese Protein aggregation: pathways, induction factors and analysis J Pharm Sci 98 2008 2909 2934
7. J.L. Cleland, M.F. Powell, and S.J. Shire The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation Crit Rev Ther Drug Carrier Syst 10 1993 307 377
8. M.E.M. Cromwell, E. Hilario, and F. Jacobson Protein aggregation and bioprocessing AAPS J 8 2006 E572 E579
9. N. Rathore, and R.S. Rajan Current perspectives on stability of protein drug products during formulation, fill and finish operations Biotechnol Prog 24 2008 504 514
10. W. Wang Protein aggregation and its inhibition in biopharmaceutics Int J Pharm 289 2005 1 30
11. W. Wang, S.K. Singh, N. Li, M.R. Toler, K.R. King, and S. Nema Immunogenicity of protein aggregates-concerns and realities Int J Pharm 431 2012 1 11
12. J.S. Philo, and T. Arakawa Mechanisms of protein aggregation Curr Pharm Biotechnol 10 2009 348 351
13. W.F.I. Weiss, T.M. Young, and C.J. Roberts Principles, approaches, and challenges for predicting protein aggregation rates and shelf life J Pharm Sci 98 2009 1246 1277
14. C.J. Roberts, T.K. Das, and E. Sahin Predicting solution aggregation rates for therapeutic proteins: approaches and challenges Int J Pharm 418 2011 1 16
15. J.S. Bee, J.L. Stevenson, B. Mehta, J. Svitel, J. Pollastrini, and R. Platz Response of a concentrated monoclonal antibody formulation to high shear Biotechnol Bioeng 103 2009 936 943
16. Y.-F. Maa, and C.C. Hsu Protein denaturation by combined effect of shear and air-liquid interface Biotechnol Bioeng 54 1997 503 512
17. Y.-F. Maa, and C.C. Hsu Effect of high shear on proteins Biotechnol Bioeng 51 1996 458 465
18. S. Kiese, A. Papppenberger, W. Friess, and H.C. Mahler Shaken, not stirred: mechanical stress testing of an IgG1 antibody J Pharm Sci 97 2008 4347 4366
19. H.-C. Mahler, R. Muller, W. Friess, A. Delille, and S. Matheus Induction and analysis of aggregates in a liquid IgG1-antibody formulation Eur J Pharm Biopharm 59 2005 407 417
20. C.R. Thomas, and D. Geer Effects of shear on proteins in solution Biotechnol Lett 33 2011 443 456
21. S. Simon, H.J. Krause, C. Weber, and W. Peukert Physical degradation of proteins in well-defined fluid flows studied within a four-roll apparatus Biotechnol Bioeng 108 2011 2914 2922
22. J.S. Bee, D. Chiu, S. Sawicki, J.L. Stevenson, K. Chatterjee, and E. Freund Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies J Pharm Sci 98 2009 3218 3238
23. A.H. Fradkin, J.F. Carpenter, and T.W. Randolph Immunogenicity of aggregates of recombinant human growth hormone in mouse models J Pharm Sci 98 2009 3247 3264
24. J.G. Biddlecombe, G. Smith, S. Uddin, S. Mulot, D. Spencer, and C. Gee Factors influencing antibody stability at solid-liquid interfaces in a high shear environment Biotechnol Prog 25 2009 1499 1507
25. A. Baszkin, M.M. Boissonnade, A. Kamyshny, and S. Magdassi Native and hydrophobically modified human immunoglobulin G at the air/water interface J Colloid Interface Sci 239 2001 1 9
26. J. Haas, E. Voehringer-Martinez, A. Boegehold, D. Matthes, U. Hensen, and A. Pelah Primary steps of pH-dependent insulin aggregation kinetics are governed by conformational flexibility Chembiochem 10 2009 1816 1822
27. A.F. Henson, J.R. Mitchell, and P.R. Musselwhite The surface coagulation of proteins during shaking J Colloid Interface Sci 32 1970 162 165
28. H.-C. Mahler, F. Senner, K. Maeder, and R. Mueller Surface activity of a monoclonal antibody J Pharm Sci 98 2009 4525 4533
29. J.S. Harrison, A. Gill, and M. Hoare Stability of a single-chain Fv antibody fragment when exposed to a high shear environment combined with air-liquid interfaces Biotechnol Bioeng 59 1998 517 519
30. S. Colombie, A. Gaunand, and B. Lindet Lysozyme inactivation under mechanical stirring: effect of physical and molecular interfaces Enzyme Microb Technol 28 2001 820 826
31. J. Jaspe, and S.J. Hagen Do protein molecules unfold in a simple shear flow Biophys J 91 2006 3415 3424
32. E. Di Stasio, and R. De Cristofaro The effect of shear stress on protein conformation: physical forces operating on biochemical systems: the case of von Willebrand factor Biophys Chem 153 2010 1 8
33. C.E. Sing, and A. Alexander-Katz Elongational flow induces the unfolding of von Willebrand factor at physiological flow rates Biophys J 98 2010 L35 L37
34. A.C. King, M. Woods, W. Liu, Z. Lu, D. Gill, and M.R.H. Krebs High-throughput measurement, correlation analysis, and machine-learning predictions for pH and thermal stabilities of Pfizer-generated antibodies Protein Sci 20 2011 1546 1557
35. J.L. Cleland, A. Mac, B. Boyd, J. Yang, E.T. Duenas, and D. Yeung The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres Pharm Res 14 1997 420 425
36. R. Pearlman, and J.Y. Wang Stability and characterization of human growth hormone R. Pearlman, J.Y. Wang, Stability and characterization of protein and peptide drugs: case histories 1993 Plenum Press New York 1 58
37. M. Cholewinski, B. Lückel, and H. Horn Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison Pharm Acta Helv 71 1996 405 419
38. B.C. Cunningham, M.G. Mulkerrin, and J. Wells Dimerization of human growth hormone by zinc Science 253 1991 545 548
39. G. Dienys, J. Sereikaite, V. Luksa, O. Jarutiene, E. Mistiniene, and V.A. Bumelis Dimerization of human growth hormone in the presence of metal ions Bioconjug Chem 11 2000 646 651
40. N.B. Bam, J.L. Cleland, J. Yang, M.C. Manning, J.F. Carpenter, and R.F. Kelley Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions J Pharm Sci 87 1998 1554 1559
41. M. Katakam, and A.K. Banga Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses Pharm Dev Technol 2 1997 143 149
42. M. Katakam, L.N. Bell, and A.K. Banga Effect of surfactants on the physical stability of recombinant human growth hormone J Pharm Sci 84 1995 713 716
43. L. Chantalat, N.D. Jones, F. Korber, J. Navaza, and A.G. Pavlovsky The crystal structure of wild-type growth hormone at 2.5 a resolution Protein Pept Lett 2 1995 333 340
44. C.P. Hill, T.D. Osslund, and D. Eisenberg The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors Proc Natl Acad Sci USA 90 1993 5167 5171
45. A.M. de Vos, M. Ultsch, and A.A. Kossiakoff Human growth hormone and extracellular domain of its receptor: crystal structure of the complex Science 255 1992 306 312
46. A.J. Jones, S. Putney, O.L. Johnson, and J.L. Cleland Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development Adv Drug Deliv Rev 28 1997 71 84
47. G.W. Becker, P.M. Tackitt, W.W. Bromer, D.S. Lefeber, and R.M. Riggin Isolation and characterization of a sulfoxide and a desamido derivative of biosynthetic human growth hormone Biotechnol Appl Biochem 10 1988 326 337
48. R. Riggin, and N. Farid Analytical chemistry of therapeutic proteins C. Horvath, J.G. Nikelly, Analytical biotechnology: capillary electrophoresis and chromatography 1990 American Chemical Society Washington, DC 113 126
49. H.A. Doyle, R.J. Gee, and M.J. Mamula Altered immunogenicity of isoaspartate containing proteins Autoimmunity 40 2007 131 137
50. M.R. Wilkins, E. Gasteiger, A. Bairoch, J.C. Sanchez, K.L. Williams, and R.D. Appel Protein identification and analysis tools in the ExPASy server Methods Mol Biol 112 1999 531 552
51. E. Gasteiger, C. Hoogland, A. Gattiker, S. Duvaud, M.R. Wilkins, and R.D. Appel Protein identification and analysis tools on the ExPASy server J.M. Walker, The proteomics protocols handbook 2005 Humana Press Inc. New York 571 607
52. B.M. Eckhardt, J.Q. Oeswein, D.A. Yeung, T.D. Milby, and T.A. Bewley A turbidimetric method to determine visual appearance of protein solutions J Pharm Sci Technol 48 1994 64 70
53. Ph. Eur. 2.2.1. Clarity and degree of opalescense of liquids, 6th edition. European Directorate for the Quality of Medicine (EDQM); 2008.
54. E. Ablinger, S. Wegscheider, W. Keller, R. Prassl, and A. Zimmer Effect of protamine on the solubility and deamidation of human growth hormone Int J Pharm 427 2012 209 216
55. J.T. Vivian, and P.R. Callis Mechanisms of tryptophan fluorescence shifts in proteins Biophys J 80 2001 2093 2109
56. I. Dib, A. Slavica, W. Riethorst, and B. Nidetzky Thermal inactivation of d-amino acid oxidase from Trigonopsis variabilis occurs via three parallel paths of irreversible denaturation Biotechnol Bioeng 94 2006 645 654
57. N.B. Bam, J.L. Cleland, and T.W. Randolph Molten globule intermediate of recombinant human growth hormone: stabilization with surfactants Biotechnol Prog 12 1996 801 809
58. A. Hawe, M. Sutter, and W. Jiskoot Extrinsic fluorescent dyes as tools for protein characterization Pharm Res 25 2008 1487 1499
59. M.D. Abramoff, P.J. Magelhaes, and S.J. Ram Image processing with ImageJ Biophotonics Int 11 2004 36 42
60. U. Roessl, J. Wiesbauer, S. Leitgeb, R. Birner-Gruenberger, and B. Nidetzky Non-native aggregation of recombinant human granulocyte-colony stimulating factor under simulated process stress conditions Biotechnol J 7 2012 1014 1024
61. N. Jenkins, L. Murphy, and R. Tyther Post-translational modifications of recombinant proteins: significance for biopharmaceuticals Mol Biotechnol 39 2008 113 118
62. L.P. Stratton, R.M. Kelly, J. Rowe, J.E. Shively, D.D. Smith, and J.F. Carpenter Controlling deamidation rates in a model peptide: effects of temperature, peptide concentration, and additives J Pharm Sci 90 2001 2141 2148
63. U.J. Lewis, E.V. Cheever, and W.C. Hopkins Kinetic study of the deamidation of growth hormone and prolactin Biochim Biophys Acta 214 1970 498 508
64. M. Sukumar, B.L. Doyle, J.L. Combs, and A.H. Pekar Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association Pharm Res 21 2004 1087 1093
65. M.C.L. Maste, E.H.W. Pap, A.V. Hoek, W. Norde, and A.J.W.G. Visser Spectroscopic investigation of the structure of a protein adsorbed on a hydrophobic latex J Colloid Interface Sci 180 1996 632 633
66. T. Zoungrana, G.H. Findenegg, and W. Norde Structure, stability and activity of adsorbed enzymes J Colloid Interface Sci 190 1997 437 448
67. S. Tissot, M. Farhat, D.L. Hacker, T. Anderlei, M. Kuehner, and C. Comninellis Determination of a scale-up factor from mixing time studies in orbitally shaken bioreactors Biochem Eng J 52 2010 181 186
68. S. Tissot, A. Oberbek, M. Reclari, M. Dreyer, D.L. Hacker, and L. Baldi Efficient and reproducible mammalian cell bioprocesses without probes and controllers? New Biotechnol 28 2011 382 390
69. M. Soos, A.S. Moussa, L. Ehrl, J. Sefcik, H. Wu, and M. Morbidelli Effect of shear rate on aggregate size and morphology investigated under turbulent conditions in stirred tank J Colloid Interface Sci 319 2008 577 589
70. J.A.S. Perez, E.M.R. Porcel, J.L.C. Lopez, J.M.F. Sevilla, and Y. Chisti Shear rate in stirred tank and bubble column bioreactors Chem Eng J 124 2006 1 5
71. P.M. Doran Bioprocess engineering principles 2000 Academic Press Limited London p. 130-63
72. J. Buechs, U. Maier, C. Milbradt, and B. Zoels Power consumption in shaking flasks on rotary shaking machines: I. Power consumption measurement in unbaffled flasks at low liquid viscosity Biotechnol Bioeng 68 2000 589 593